𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Concurrent cisplatin, etoposide, and radiotherapy for unresectable Stage III nonsmall cell lung cancer: A Phase II study

✍ Scribed by François Reboul; Yvelise Brewer; Pascal Vincent; Bruno Chauvet; Caroline Félix Faure; Marc Taulelle

Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
848 KB
Volume
35
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan and cisplatin with concurrent
Irinotecan and cisplatin with concurrent split-course radiotherapy in locally advanced nonsmall-cell lung cancer : A multiinstitutional phase 2 study
✍ Minoru Fukuda; Hiroshi Soda; Masaaki Fukuda; Akitoshi Kinoshita; Yoichi Nakamura 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views

## Abstract ## BACKGROUND. The purpose was to determine the efficacy and toxicity of irinotecan and cisplatin with concurrent split‐course thoracic radiotherapy (TRT) in locally advanced nonsmall‐cell lung cancer. ## METHODS. Fifty patients fulfilling the following eligibility criteria were enro

Phase II trial of etoposide and cisplati
Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: A cancer and leukemia group B study
✍ Graziano, Stephen L. ;Lee, Kewchang ;Propert, Kathleen J. ;Tinsley, Roger ;Hayes 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 1 views

## Abstract A phase II trial of etoposide and cisplatin for patients with previously treated small cell lung cancer was carried out by CALGB from June 1983 to May 1984. Thirty‐five evaluable patients who had failed one prior chemotherapy regimen were treated with etoposide 80 mg/m^2^ and cisplatin